Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.32 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.30 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL713 | 0.78 | KDM4E (0.46) | TSHRKDM4EGAASMN1; SMN2 | |
| SCHEMBL472 | 0.77 | KDM4E (0.39) | TSHRKDM4EGAA | |
| Hydrochloric Acid SCHEMBL7276912 | 0.75 | KDM4E (0.38) | TSHRKDM4EGAA | |
| SCHEMBL9321576 | 0.72 | KDM4E (0.40) | TSHRKDM4EGAAPDE4APDE4B | |
| Hydrochloric Acid SCHEMBL9281270 | 0.70 | KDM4E (0.36) | TSHRKDM4EGAA | |
| SCHEMBL993 | 0.66 | KDM4E (0.46) | TSHRKDM4EGAASMN1; SMN2 | |
| SCHEMBL8142567 | 0.66 | SMN1; SMN2 (0.47) | TSHRKDM4EGAASMN1; SMN2 | |
| SCHEMBL7274394 | 0.66 | KDM4E (0.36) | TSHRKDM4EGAASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL7277644 | 0.65 | KDM4E (0.36) | TSHRKDM4EGAA | |
| SCHEMBL4200809 | 0.64 | KDM4E (0.37) | TSHRKDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5360800-A | Tetrahydro-1H-pyrido[4,3-b]indol-1-one derivatives | GLAXO GROUP LIMITED (GB) | 1994-11-01 | — | — | US | disclosed |
| US-5183820-A | Useful for treatment of nausea, vomiting, irritable bowel syndrome and dyspepsia | GLAXO GROUP LIMITED (GB) | 1993-02-02 | — | — | US | disclosed |
| US-5026722-A | Antagonists of 5-hydroxytryptamine | GLAXO GROUP LIMITED (GB) | 1991-06-25 | — | — | US | disclosed |
| EP-0306323-A2 | Lactam derivatives | GLAXO GROUP LIMITED (GB) | 1989-03-08 | — | — | EP | disclosed |